Taiwan-based vaccine maker Medigen will conduct a Phase 3 clinical trial for its COVID-19 vaccine in Europe once it has received approval from European authorities, which would help pave the way for its entry into European and other international markets, the company announced Wednesday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Starlux showcases Taiwan's 1st Airbus A350-1000 at Singapore Airshow
02/03/2026 09:54 PM - Politics
TPP lawmaker sworn in as nationality status remains unresolved
02/03/2026 09:53 PM - Cross-Strait
Tourism reps call for more exchanges at KMT-CCP think tank forum
02/03/2026 09:41 PM - Society
Vietnamese man sentenced to over 8 years for animal killings
02/03/2026 09:37 PM - Society
Banks instructed to freeze 'high-risk' accounts of departed foreigners
02/03/2026 09:26 PM